RedHill Biopharma (RDHL) Gains from Investment Securities (2012 - 2023)
RedHill Biopharma (RDHL) posted Gains from Investment Securities of $1.69 million for the quarter ended Sep 30, 2017, up 188.0% from $585,000 a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Gains from Investment Securities (2012 - 2023) Analysis & Trends
For the trailing twelve months through Sep 30, 2017, Gains from Investment Securities at RedHill Biopharma was -$2.85 million; for the year ended Dec 31, 2016, it was -$1.15 million.
- In prior years, RedHill Biopharma's Gains from Investment Securities was -$888,000 in the year ended Dec 31, 2015 and -$200,000 in the year ended Dec 31, 2014.
- The figure for the quarter ended Sep 30, 2017 stands as the highest quarterly Gains from Investment Securities since the quarter ended Mar 31, 2014.
- According to Business Quant data, Gains from Investment Securities for the three prior quarters was -$2.25 million (quarter ended Jun 30, 2017), -$1.26 million (quarter ended Mar 31, 2017) and -$1.02 million (quarter ended Dec 31, 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | RedHill Biopharma | 2.14 Mn | -14.47 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 9.07 Mn |
| Mar 31, 2023 | -996,000.00 |
| Dec 31, 2022 | 18.55 Mn |
| Sep 30, 2022 | -3.14 Mn |
| Dec 31, 2021 | -11,000.00 |
| Sep 30, 2021 | 12,000.00 |
| Jun 30, 2021 | -12,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Dec 31, 2020 | -162,000.00 |
| Sep 30, 2020 | 31,000.00 |
| Jun 30, 2020 | 38,000.00 |
| Mar 31, 2020 | 75,000.00 |
| Dec 31, 2019 | 417,000.00 |
| Sep 30, 2019 | 14,000.00 |
| Jun 30, 2019 | 1.30 Mn |
| Mar 31, 2019 | -52,000.00 |
| Dec 31, 2018 | -277,000.00 |
| Sep 30, 2018 | 28,000.00 |
| Jun 30, 2018 | -1.67 Mn |
| Mar 31, 2018 | 99,000.00 |
API Access
RedHill Biopharma Gains from Investment Securities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-investment-securities", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();